WEBSITE BSE:539334 NSE : SHREEPUSHK 10 May, 16:01
Market Cap ₹543 Cr.
Stock P/E 14.7
P/B 1.2
Current Price ₹171.6
Book Value ₹ 145.9
Face Value 10
52W High ₹242
Dividend Yield 0.87%
52W Low ₹ 155
Shree Pushkar Chemicals & Fertilisers Ltd is an totally India-based business enterprise, which is engaged within the enterprise of manufacturing and trading of chemical compounds, dyes and dyes intermediate, cattle feeds, fertilizers and soil conditioner. The Company's dye merchandise consist of acid dyes, direct dyes and reactive dyes below product names, inclusive of Leather Brown GG, Brown GR, Red F3B, Fast Red 46, Yellow GR and Yellow FG. Its cattle feed dietary supplements encompass Pushp Ahaar and Di Calcium Phosphate (DCP). Its fertilizers department gives products, consisting of SSP, SC, NPK and SOP. It additionally offers Dharti Ratna, a soil conditioner primarily based on Gypsum. Its acids department includes Sulphuric 98%, Oleum 23%, Oleum 65% and Chloro Sulphonic acid. The Company's production centres provide a number of chemical reactions, which include sulfonation, nitration, acetylation, reduction, condensation, isolation, hydrolysis, amination, fusion and acetylation. The Company is targeted on Toll Manufacturing.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 136 | 137 | 192 | 169 | 181 | 154 | 180 | 176 | 185 | 175 |
Other Income | 2 | 2 | 1 | 1 | 3 | 2 | 2 | 2 | 3 | 3 |
Total Income | 138 | 139 | 193 | 170 | 184 | 156 | 182 | 177 | 188 | 178 |
Total Expenditure | 114 | 118 | 173 | 148 | 168 | 141 | 160 | 162 | 171 | 161 |
Operating Profit | 25 | 21 | 21 | 22 | 16 | 15 | 22 | 16 | 17 | 17 |
Interest | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 |
Depreciation | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 21 | 17 | 17 | 18 | 11 | 10 | 17 | 10 | 11 | 11 |
Provision for Tax | 5 | 5 | 3 | 3 | 6 | 5 | 4 | 2 | 3 | 4 |
Profit After Tax | 16 | 12 | 14 | 14 | 5 | 5 | 13 | 8 | 8 | 8 |
Adjustments | -0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 16 | 12 | 14 | 14 | 5 | 5 | 13 | 8 | 8 | 8 |
Adjusted Earnings Per Share | 5.1 | 4 | 4.5 | 4.6 | 1.5 | 1.6 | 4.1 | 2.5 | 2.7 | 2.4 |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|
Net Sales | 306 | 395 | 452 | 346 | 355 | 584 | 684 | 716 |
Other Income | 2 | 2 | 3 | 4 | 7 | 7 | 8 | 10 |
Total Income | 308 | 397 | 455 | 351 | 362 | 591 | 692 | 725 |
Total Expenditure | 254 | 334 | 385 | 297 | 312 | 505 | 616 | 654 |
Operating Profit | 54 | 63 | 70 | 54 | 50 | 87 | 76 | 72 |
Interest | 3 | 3 | 4 | 2 | 1 | 2 | 2 | 2 |
Depreciation | 5 | 8 | 10 | 11 | 13 | 14 | 19 | 20 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 46 | 52 | 56 | 40 | 36 | 71 | 56 | 49 |
Provision for Tax | 16 | 16 | 15 | 4 | 7 | 15 | 18 | 13 |
Profit After Tax | 30 | 37 | 41 | 36 | 29 | 56 | 37 | 37 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 30 | 37 | 41 | 36 | 29 | 56 | 37 | 37 |
Adjusted Earnings Per Share | 10 | 12.1 | 13.3 | 11.6 | 9.3 | 18 | 11.8 | 11.7 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 17% | 26% | 12% | 0% |
Operating Profit CAGR | -13% | 12% | 4% | 0% |
PAT CAGR | -34% | 1% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -1% | -1% | 3% | NA% |
ROE Average | 9% | 11% | 12% | 14% |
ROCE Average | 12% | 13% | 14% | 16% |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Shareholder's Funds | 193 | 237 | 284 | 306 | 339 | 396 | 438 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 1 | 3 | 7 | 4 | 8 | 8 | 2 |
Other Non-Current Liabilities | 11 | 14 | 21 | 19 | 23 | 30 | 36 |
Total Current Liabilities | 55 | 137 | 114 | 114 | 119 | 204 | 188 |
Total Liabilities | 260 | 391 | 426 | 444 | 489 | 637 | 664 |
Fixed Assets | 123 | 166 | 172 | 164 | 175 | 195 | 313 |
Other Non-Current Assets | 14 | 14 | 24 | 119 | 154 | 132 | 12 |
Total Current Assets | 123 | 211 | 230 | 161 | 161 | 310 | 339 |
Total Assets | 260 | 391 | 426 | 444 | 489 | 637 | 664 |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 | 1 | 3 | 13 |
Cash Flow from Operating Activities | 17 | -5 | 56 | 76 | 41 | 42 | 50 |
Cash Flow from Investing Activities | -12 | -50 | -40 | -61 | -33 | -63 | -38 |
Cash Flow from Financing Activities | -5 | 55 | -15 | -14 | -7 | 31 | -22 |
Net Cash Inflow / Outflow | 0 | -0 | 0 | 0 | 2 | 10 | -9 |
Closing Cash & Cash Equivalent | 0 | 0 | 1 | 1 | 3 | 13 | 4 |
# | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 10 | 12.09 | 13.29 | 11.58 | 9.25 | 18.01 | 11.77 |
CEPS(Rs) | 11.82 | 14.67 | 16.54 | 15.3 | 13.36 | 22.6 | 17.63 |
DPS(Rs) | 1.5 | 0 | 1.5 | 0.5 | 1 | 2 | 1.5 |
Book NAV/Share(Rs) | 63.86 | 74.15 | 89.71 | 99.3 | 109.93 | 127.05 | 138.37 |
Core EBITDA Margin(%) | 16.95 | 15.45 | 14.79 | 14.24 | 12.18 | 13.61 | 10 |
EBIT Margin(%) | 15.87 | 13.93 | 13.18 | 12.16 | 10.51 | 12.45 | 8.45 |
Pre Tax Margin(%) | 15.04 | 13.21 | 12.36 | 11.55 | 10.1 | 12.12 | 8.13 |
PAT Margin (%) | 9.88 | 9.25 | 9.04 | 10.31 | 8.04 | 9.51 | 5.44 |
Cash Profit Margin (%) | 11.67 | 11.22 | 11.24 | 13.62 | 11.6 | 11.93 | 8.15 |
ROA(%) | 11.63 | 11.23 | 10 | 8.21 | 6.12 | 9.86 | 5.72 |
ROE(%) | 15.66 | 17.53 | 16.35 | 12.28 | 8.85 | 15.2 | 8.98 |
ROCE(%) | 23.33 | 21.59 | 18.8 | 12.23 | 9.9 | 16.47 | 11.65 |
Receivable days | 72.8 | 67.86 | 74.41 | 92.21 | 78.99 | 53.61 | 59.38 |
Inventory Days | 37.97 | 52.69 | 58.39 | 65.54 | 60.37 | 45.94 | 46.52 |
Payable days | 38.62 | 49.07 | 57.5 | 83.55 | 88.59 | 68.85 | 76.7 |
PER(x) | 20.04 | 16.77 | 12.38 | 6.38 | 14.77 | 15.52 | 12.56 |
Price/Book(x) | 3.14 | 2.74 | 1.83 | 0.74 | 1.24 | 2.2 | 1.07 |
Dividend Yield(%) | 0.75 | 0 | 0.91 | 0.68 | 0.73 | 0.72 | 1.01 |
EV/Net Sales(x) | 1.96 | 1.67 | 1.13 | 0.8 | 1.34 | 1.61 | 0.78 |
EV/Core EBITDA(x) | 11.07 | 10.48 | 7.38 | 5.19 | 9.52 | 10.82 | 6.95 |
Net Sales Growth(%) | 0 | 29.22 | 14.33 | -23.36 | 2.48 | 64.54 | 17.13 |
EBIT Growth(%) | 0 | 13.49 | 8.12 | -29.27 | -11.43 | 94.93 | -20.52 |
PAT Growth(%) | 0 | 20.95 | 11.76 | -12.57 | -20.09 | 94.65 | -32.97 |
EPS Growth(%) | 0 | 20.95 | 9.92 | -12.89 | -20.09 | 94.65 | -34.64 |
Debt/Equity(x) | 0.08 | 0.29 | 0.17 | 0.17 | 0.17 | 0.23 | 0.16 |
Current Ratio(x) | 2.22 | 1.54 | 2.03 | 1.41 | 1.35 | 1.52 | 1.8 |
Quick Ratio(x) | 1.65 | 0.94 | 1.48 | 0.87 | 0.89 | 1.07 | 1.36 |
Interest Cover(x) | 19.13 | 19.26 | 16.03 | 19.78 | 25.7 | 37.1 | 26.11 |
Total Debt/Mcap(x) | 0.02 | 0.11 | 0.09 | 0.23 | 0.14 | 0.11 | 0.15 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 67.03 | 67.61 | 68.42 | 68.42 | 68.42 | 68.6 | 68.6 | 68.6 | 68.6 | 68.6 |
FII | 1.44 | 1.28 | 1.34 | 1.4 | 1.35 | 1.33 | 1.37 | 1.35 | 1.35 | 1.39 |
DII | 1.25 | 1.25 | 1.22 | 1.14 | 1.14 | 1.14 | 1.06 | 1.04 | 0.75 | 0 |
Public | 30.28 | 29.86 | 29.03 | 29.04 | 29.1 | 28.94 | 28.96 | 29 | 29.3 | 30.01 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 2.07 | 2.08 | 2.16 | 2.16 | 2.16 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 |
FII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
DII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 | 0 |
Public | 0.93 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.93 | 0.95 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3.08 | 3.08 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About